A 32-year-old woman presents with acute joint pain, fever, and a palpable purpura rash on her lower extremities 1 week after receiving penicillin for a throat infection. Which single finding best distinguishes her condition (Type III hypersensitivity) from an acute Type I hypersensitivity reaction to the same drug?

Explanation

## Type III vs Type I Hypersensitivity: Clinical Discrimination ### Clinical Presentation Analysis The patient's presentation — **delayed onset (1 week), systemic symptoms (fever, arthralgia), palpable purpura, and glomerulonephritis** — is classic **serum sickness** (Type III hypersensitivity). ### Pathophysiologic Distinction **Key Point:** The defining difference is **where and how antibodies cause damage**: | Aspect | Type I (Anaphylaxis) | Type III (Serum Sickness) | |--------|----------------------|---------------------------| | **Antibody** | IgE (cell-bound on mast cells) | IgG/IgM (circulating) | | **Mechanism** | Cross-linking of IgE → immediate degranulation | Antigen-antibody complex → tissue deposition | | **Deposition site** | Mast cells in tissues | Blood vessel walls, glomeruli, joints | | **Onset** | Minutes | 7–10 days (after immune complex formation) | | **Symptoms** | Urticaria, angioedema, bronchospasm, hypotension | Arthralgia, fever, rash, glomerulonephritis | | **Histology** | Mast cell degranulation | Vasculitis, immune complex in vessel walls | ### Why Immune Complex Deposition Is the Discriminator **High-Yield:** In Type I, the pathology is **mast cell activation** in skin and airways. In Type III, the pathology is **immune complex-mediated vasculitis** in small vessels and glomeruli. This explains why the patient has: - Palpable purpura (vasculitis, not urticaria) - Glomerulonephritis (complex deposition in kidneys) - Systemic symptoms (circulating complexes) **Clinical Pearl:** Serum sickness is self-limited (1–3 weeks) because the antigen (penicillin) is cleared and immune complex formation stops. Type I anaphylaxis is immediate and life-threatening. **Mnemonic:** **VASCULITIS = Type III** (immune complex disease); **MAST CELLS = Type I** (IgE-mediated).